Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

906
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
906
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

918
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
918
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

572
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
572
Cholecystitis01:20

Cholecystitis

32
Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
32
Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

27
Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80%...
27
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

35
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
35

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chromosomal anomalies in radiation-induced fibrosis in the pig.

Mutation research·1992
Same author

Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation.

The Journal of infectious diseases·1992
Same author

Myths and realities of antiemetic treatment.

The British journal of cancer. Supplement·1992
Same author

Quebec medical organizations another sign of province's "distinct society".

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·1992
Same author

[Prognostic effect of beta 2-microglobulin in multiple myeloma].

Medicina clinica·1992
Same author

Threat of nuclear war subsides, but antiwar MDs say lots of work remains.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·1992
Same journal

Dupilumab Emerges as an Effective Antibody Therapy for Eosinophilic Esophagitis.

Annual review of medicine·2026
Same journal

CAR T Cell Toxicities and Emerging Treatment Strategies.

Annual review of medicine·2026
Same journal

Transthyretin Amyloid Cardiomyopathy: A Rapidly Evolving Landscape.

Annual review of medicine·2026
Same journal

Accessibility of Somatic Genetic Testing for Cancer Treatment Decisions.

Annual review of medicine·2026
Same journal

Diffuse Parenchymal Lung Disease: Updates in Pathophysiology and Management.

Annual review of medicine·2026
Same journal

Revascularization for Ischemic Cardiomyopathy: Disproving the 45-Year-Old Concept of Hibernating Myocardium.

Annual review of medicine·2026
See all related articles

Related Experiment Video

Updated: May 5, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

22.1K

Primary sclerosing cholangitis

M Martin1

  • 1Pittsburgh Transplant Institute, Pennsylvania.

Annual Review of Medicine
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Primary sclerosing cholangitis (PSC) is a rare, progressive biliary disease often linked to autoimmune and genetic factors. Diagnosis relies on characteristic imaging, with liver transplantation being the definitive treatment for advanced cases.

More Related Videos

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology
12:36

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology

Published on: March 14, 2020

16.3K
A Two-Step Method for Percutaneous Transhepatic Choledochoscopic Lithotomy
03:56

A Two-Step Method for Percutaneous Transhepatic Choledochoscopic Lithotomy

Published on: September 13, 2022

2.8K

Related Experiment Videos

Last Updated: May 5, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

22.1K
Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology
12:36

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology

Published on: March 14, 2020

16.3K
A Two-Step Method for Percutaneous Transhepatic Choledochoscopic Lithotomy
03:56

A Two-Step Method for Percutaneous Transhepatic Choledochoscopic Lithotomy

Published on: September 13, 2022

2.8K

Area of Science:

  • Hepatology
  • Immunology
  • Genetics

Background:

  • Primary sclerosing cholangitis (PSC) is an idiopathic inflammatory biliary disease.
  • It involves fibrosis and obliteration of bile ducts, often coexisting with autoimmune conditions and specific genetic markers.
  • PSC can progress slowly or rapidly to cirrhosis and portal hypertension.

Purpose of the Study:

  • To review the etiology, diagnosis, and management of Primary Sclerosing Cholangitis.
  • To highlight the diagnostic role of radiological imaging.
  • To discuss current therapeutic options, including liver transplantation.

Main Methods:

  • Review of existing literature on Primary Sclerosing Cholangitis.
  • Analysis of clinical presentation, diagnostic criteria, and treatment outcomes.
  • Emphasis on radiological and endoscopic diagnostic modalities.

Main Results:

  • PSC diagnosis is primarily based on characteristic radiological findings.
  • No effective medical treatments currently exist for PSC.
  • Liver transplantation is the established definitive therapy for complicated PSC.

Conclusions:

  • PSC is a complex inflammatory biliary disease with suspected autoimmune and genetic links.
  • Radiological patterns are key for diagnosis.
  • Liver transplantation offers the best outcome for patients with advanced PSC.